Skip to content

RoosterBio Logo

Site Navigation

  • Our Technology
    • Foundation for Multiple Therapeutics
    • Powerful Technology
    • Built-In Manufacturing Process
  • Products
    • Human Primary Cells
      • Bone Marrow-derived hMSCs
      • Adipose-derived hMSCs
      • Umbilical Cord-derived hMSCs
      • Neonatal Dermal Fibroblasts
      • QuickShip™ Cell Banks
    • Cell & Exosome Media
      • hMSC Expansion Media
      • hMSC Bioreactor Feed
      • Exosome Media
      • QuickShip™ MSC & Exosome Media
    • cGMP CliniControl™ Products
      • Human Primary Cells
      • hMSC Expansion Media
      • hMSC Bioreactor Feed
      • Exosome Media
      • Genetic Engineering Media
    • Engineered Human Cell Lines
      • hTERT-Modified hMSCs
    • Genetic Engineering Tools
      • Genetic Engineering Media
    • Cell & Media Kits
      • hMSC Starter Kits
      • hMSC Donor & Tissue Screening Kits
      • hMSC & Exosome Bioreactor Kits
    • Human Exosomes / Extracellular Vesicles
      • MSC-Derived Exosomes
      • QuickShip™ Exosomes
      • QuickShip™ Downstream Processing
  • Services
    • Process Development Services
    • hMSC Analytical Services
    • Exosome/Extracellular Vesicle Analytical Services
    • QuickShip™ Solutions
  • Knowledge Center
    • Resources
    • CoAs & QC Briefs
    • Publications
    • Videos & Webinars
    • Blog Articles
  • About Us
    • Why RoosterBio?
    • Our Leadership
    • Our Collaborators
    • Our Culture
    • Careers
    • FAQs
  • News & Events
    • News
    • Events
    • Press Releases
    • Media Kit
  • Contact Us

Publications

MMP-9 enhanced Mesenchymal stem cells for the treatment of liver fibrosis

June 2024 Bioprinting, Bioprocessing, Cell Therapy, Clinical, Gene Editing, Genetic, Immunomodulation, MedTech, Devices, & Materials, Orthopedic, Tissue Engineering

Gene activated reinforced scaffolds for SOX9 delivery to enhance repair of large load bearing articular cartilage defects

May 2024 Bioprinting, Bioprocessing, Gene Editing, MedTech, Devices, & Materials, Orthopedic, Tissue Engineering

Cytokine Receptor-like Factor 1 (CRLF1) and Its Role in Osteochondral Repair

May 2024 Bioprinting, Bioprocessing, Cardiovascular, Gene Editing, Immunomodulation, Orthopedic, Tissue Engineering

Developing Technological Platforms for Targeted Cancer Therapies, Protein Drug Delivery, and Pathogen Detection

May 2024 Bioprinting, Cancer, Cell Therapy, Clinical, Exosomes / Extracellular Vesicles, Gene Editing, MedTech, Devices, & Materials, Tissue Engineering

Stepwise Stiffening/Softening of and Cell Recovery from Reversibly Formulated Hydrogel Double Networks

April 2024 Bioprinting, Cancer, Gene Editing, MedTech, Devices, & Materials, Tissue Engineering

A MODIFIED DELPHI STUDY TO ESTABLISH REPORTING GUIDELINES FOR CLINICAL STUDIES USING MESENCHYMAL STROMAL CELL (MSC)

January 2024 Bioprocessing, Cell Therapy, Clinical, Gene Editing, Immunomodulation

Development of Gene Delivery Coating for Orthopedic Implants: Enhanced Gap Junction Communication in MSCs Accelerates Ischemic Bone Fracture Healing

January 2024 Gene Editing, Orthopedic

Recent Advances in Extracellular Vesicle Engineering & Its Applications to Regenerative Medicine

December 2023 Bioprocessing, Exosomes / Extracellular Vesicles, Gene Editing, Genetic, Pain, Renal

Application of Human Platelet Lysate in Chondrocyte Expansion Promotes Chondrogenic Phenotype & Slows Senescence Progression Via BMP–TAK1–p38 Pathway

November 2023 Bioprinting, Cell Therapy, Clinical, Gene Editing, Orthopedic, Tissue Engineering

Dual Targeted Extracellular Vesicles Regulate Oncogenic Genes in Advanced Pancreatic Cancer

October 2023 Bioprinting, Cancer, Cell Therapy, Clinical, Exosomes / Extracellular Vesicles, Gene Editing, Genetic, Tissue Engineering
Previous 1 2 3 4 5 Next

Sidebar Navigation

  • Bioprinting
  • Bioprocessing
  • Blood
  • Cancer
  • Cardiovascular
  • Cell Therapy
  • Clinical
  • Dermal and Wound
  • Diabetes
  • Drug Screening
  • Exosomes / Extracellular Vesicles
  • Gene Editing
  • Genetic
  • Immunomodulation
  • Lung
  • MedTech, Devices, & Materials
  • Orthopedic
  • Pain
  • Pulmonary
  • Renal
  • Tech Segment
  • Therapeutic Indication
  • Tissue Engineering

Contact Information

RoosterBio, Inc.
5295 Westview Drive, Suite 275
Frederick, MD 21703
Customer Service: +1 240-831-4914
Headquarters: +1 301-200-5366
Email: info@roosterbio.com

Share

  • Twitter
  • Facebook
  • YouTube
  • LinkedIn

Footer Navigation

  • Our Technology
  • Services
  • About Us
  • News & Events
  • Contact Us
  • Login
  • Products
    • Human Primary Cells
    • Cell & Exosome Media
    • Human Exosomes / Extracellular Vesicles
    • Genetic Engineering Tools
    • Cell & Media Kits
    • cGMP CliniControl™ Products
  • Knowledge Center
    • Resources
    • Blog Articles
    • Publications
    • Videos & Webinars

Copyright © 2026 RoosterBio, Inc. All Rights Reserved / Privacy Policy / Website design by Celerate

  • Share on Facebook
  • Tweet
  • Share on LinkedIn
  • Email